Core Viewpoint - Hologic (HOLX) is expected to report a slight decline in quarterly earnings and revenues compared to the previous year, with analysts maintaining their consensus estimates over the last month [1][2]. Revenue Projections - Total revenues are forecasted to be $1.01 billion, reflecting a year-over-year decrease of 0.4% [1]. - Specific revenue estimates include: - GYN surgical revenues projected at $179.82 million, a year-over-year increase of 7.9% [4]. - Diagnostics - Molecular diagnostics expected to reach $316.12 million, up 1.8% from the prior year [4]. - Diagnostics - Blood screening anticipated at $5.65 million, down 28.5% year-over-year [5]. - Breast health - Breast imaging revenues estimated at $277.39 million, a decrease of 10.3% [5]. - Total Diagnostics revenues projected at $437.46 million, indicating a decline of 0.8% [5]. - Skeletal health revenues expected to be $25.34 million, up 33.4% from the previous year [6]. - Diagnostics - Cytology and perinatal forecasted at $117.36 million, down 4% [6]. - Total Breast health revenues estimated at $363.15 million, a decrease of 5.7% [6]. - Breast health - Interventional breast solutions projected at $85.76 million, an increase of 13.1% [7]. - Service and other revenues expected to be $202.73 million, up 1.3% [7]. - Product revenues anticipated at $801.50 million, down 1.2% from the prior year [7]. Stock Performance - Hologic shares have increased by 1.5% over the past month, compared to a 4.6% increase in the Zacks S&P 500 composite [8]. - The company holds a Zacks Rank 4 (Sell), indicating expectations of underperformance relative to the overall market in the near term [8].

Core Insights - Electronic Arts (EA) is expected to report quarterly earnings of $0.10 per share, reflecting an 80.8% decline year-over-year [1] - Analysts forecast revenues of $1.24 billion, indicating a 1.7% decrease compared to the previous year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, suggesting analysts have reassessed their projections [1] Revenue Composition - Analysts estimate 'Net revenue by composition - Live services and other - Non-GAAP (Net Bookings)' at $1.03 billion, a year-over-year decline of 5.5% [4] - The estimated 'Net revenue by composition - Full game - Full game downloads - Non-GAAP (Net Bookings)' is projected to be $139.30 million, down 2.6% from the year-ago quarter [4] - For 'Net revenue by composition - Full game - Packaged goods - Non-GAAP (Net Bookings)', the estimate is $24.02 million, reflecting a 3.9% decrease year-over-year [5] Market Performance - EA's shares have decreased by 3.2% over the past month, contrasting with the Zacks S&P 500 composite's increase of 4.6% [5] - Despite the recent decline, EA holds a Zacks Rank 2 (Buy), indicating expectations of outperforming the overall market in the near term [5]

Core Insights - UnitedHealth Group (UNH) is expected to report quarterly earnings of $4.84 per share, reflecting a year-over-year decline of 28.8% [1] - Revenue projections stand at $111.55 billion, indicating a 12.8% increase from the previous year [1] - The consensus EPS estimate has been revised downward by 6.6% over the past 30 days, showing analysts' reassessment of their initial projections [1][2] Revenue Projections - Analysts forecast 'Revenues- Products' to be $13.56 billion, representing an 11% year-over-year increase [3] - 'Revenues- Services' are expected to reach $9.37 billion, indicating a 7% year-over-year change [4] - 'Revenues- Premiums' are projected at $87.23 billion, reflecting a 13.4% increase from the prior year [4] - 'Revenues- Investment and other income' is estimated at $1.03 billion, showing a 3.5% increase from the previous year [4] Operating Statistics - The 'Medical Care Ratio' is predicted to be 88.6%, up from 85.1% in the same quarter last year [5] - The 'UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Risk-based' is estimated at 8.48 million, down from 8.74 million year-over-year [5] - 'UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Fee-based' is expected to reach 21.54 million, compared to 20.84 million in the same quarter last year [6] Customer Profile Estimates - The total 'People Served - Community and Senior' is projected at 20.28 million, up from 19.52 million year-over-year [6] - 'People Served - Community and Senior - Medicare Advantage' is estimated at 8.31 million, compared to 7.77 million last year [7] - 'People Served - Community and Senior - Medicaid' is expected to be 7.65 million, up from 7.41 million year-over-year [7] - 'People Served - Community and Senior - Medicare Supplement (Standardized)' is projected at 4.31 million, slightly down from 4.34 million last year [8] - 'People Served - Medicare Part D stand-alone' is estimated at 2.78 million, down from 3.07 million year-over-year [8] Stock Performance - Over the past month, shares of UnitedHealth have declined by 3.2%, while the Zacks S&P 500 composite has increased by 5.7% [9] - UNH currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the overall market in the near future [9]

Core Viewpoint - Analysts expect Procter & Gamble (PG) to report quarterly earnings of $1.43 per share, reflecting a year-over-year increase of 2.1%, with revenues projected at $20.82 billion, up 1.4% from the previous year [1] Earnings Projections - The consensus EPS estimate has been revised downward by 0.1% over the past 30 days, indicating a collective reassessment by analysts [1][2] - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [2] Key Metrics Estimates - Analysts estimate 'Net sales- Beauty' at $3.77 billion, indicating a year-over-year change of +1.1% [4] - 'Net sales- Grooming' is projected to reach $1.69 billion, reflecting a +2% change year-over-year [4] - 'Net sales- Corporate' is expected to be $186.14 million, showing a decline of -7.9% from the previous year [4] - 'Net sales- Fabric & Home Care' is estimated at $7.37 billion, with a +1.4% year-over-year change [5] - 'Net sales- Baby, Feminine & Family Care' is projected at $5.02 billion, indicating a +0.1% change [5] - 'Net sales- Health Care' is expected to be $2.74 billion, reflecting a +2.7% change year-over-year [5] Organic Sales Growth - 'Organic Sales Growth (YoY change) - Beauty' is expected at 1.8%, down from 3.0% reported in the same quarter last year [6] - 'Organic Sales Growth (YoY change) - Grooming' is forecasted at 3.2%, compared to 7.0% in the previous year [6] - 'Organic Sales Growth (YoY change) - Health Care' is anticipated to be 3.2%, down from 4.0% reported last year [7] Earnings Before Income Taxes - 'Earnings before income taxes- Beauty' is estimated at $767.63 million, up from $690.00 million year-over-year [7] - 'Earnings before income taxes- Grooming' is projected at $429.38 million, compared to $395.00 million last year [8] - 'Earnings before income taxes- Health Care' is expected to reach $454.46 million, up from $433.00 million in the same quarter last year [8] Stock Performance - Over the past month, P&G shares have recorded a return of -0.4%, while the Zacks S&P 500 composite has changed by +5.7% [8] - Based on its Zacks Rank 3 (Hold), P&G is expected to perform in line with the overall market in the upcoming period [8]

Core Insights - Corning (GLW) is expected to report quarterly earnings of $0.57 per share, reflecting a 21.3% increase year-over-year, with revenues projected at $3.85 billion, a 6.9% increase from the previous year [1] Financial Projections - Analysts forecast 'Net Sales- Display Technologies' to reach $919.85 million, indicating a decline of 9.3% from the year-ago quarter [4] - 'Net Sales- Optical Communications' is expected to be $1.47 billion, showing a year-over-year increase of 31.7% [4] - 'Net Sales- Specialty Materials' is projected at $520.03 million, reflecting a 3.8% increase from the prior-year quarter [4] - 'Net Sales- Life Sciences' is estimated at $245.70 million, indicating a decrease of 1.3% from the previous year [5] - 'Net Sales- Hemlock and Emerging Growth Businesses' is expected to be $270.90 million, suggesting an 8.5% decline year-over-year [5] Segment Net Income Estimates - 'Segment Net Income- Display Technologies' is projected to be $233.14 million, down from $258.00 million in the same quarter last year [6] - 'Segment Net Income- Life Sciences' is expected to reach $16.13 million, compared to $17.00 million reported in the previous year [6] - 'Segment Net Income- Optical Communications' is forecasted at $202.79 million, up from $143.00 million year-over-year [7] - 'Segment Net Income- Specialty Materials' is anticipated to be $76.36 million, compared to $63.00 million in the same quarter last year [7] Market Performance - Corning's shares have increased by 8.6% over the past month, outperforming the Zacks S&P 500 composite, which rose by 5.7% [7] - The company holds a Zacks Rank 1 (Strong Buy), indicating expectations of outperforming the overall market in the near future [7]

Core Insights - Exelixis (EXEL) is expected to report quarterly earnings of $0.63 per share, reflecting a year-over-year decline of 25% [1] - Anticipated revenues are projected at $574.51 million, indicating a decrease of 9.8% compared to the same quarter last year [1] Earnings Projections - The consensus EPS estimate has been revised downward by 0.4% in the past 30 days, indicating a reassessment by analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3] Revenue Estimates - Analysts expect 'Revenues- Net product' to be $522.61 million, representing a year-over-year increase of 19.4% [4] - The estimated 'Revenues- Collaboration services' is projected at $51.23 million, showing a significant year-over-year change of 1011% [5] - The consensus estimate for 'Revenues- Net product- COMETRIQ' is $3.58 million, reflecting a decline of 15.7% from the previous year [5] - 'Revenues- Net product- CABOMETYX' is expected to reach $527.01 million, indicating a year-over-year increase of 21.6% [5] Stock Performance - Exelixis shares have decreased by 2.7% over the past month, contrasting with the Zacks S&P 500 composite's increase of 5.9% [6] - With a Zacks Rank 2 (Buy), Exelixis is anticipated to outperform the overall market in the near term [6]

Core Viewpoint - Analysts forecast that Principal Financial (PFG) will report quarterly earnings of $1.98 per share, reflecting a year-over-year increase of 21.5%, while revenues are expected to be $4 billion, a decrease of 1.7% compared to the previous year [1]. Earnings Projections - The consensus EPS estimate for the quarter has been revised upward by 0.3% over the past 30 days, indicating a collective reassessment by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts estimate 'Revenue- Net investment income' will reach $1.19 billion, a change of +9.8% year-over-year [5]. - 'Revenue- Premiums and other considerations' is projected at $1.89 billion, indicating a -1.7% change from the prior year [5]. - 'Revenue- Fees and other revenues' is expected to be $1.08 billion, reflecting a +1.8% change year-over-year [5]. Segment-Specific Revenue Projections - 'Revenue- Principal Asset Management Segment- Net investment income' is estimated at $179.23 million, a +9% change from the previous year [6]. - 'Revenue- Benefits and Protection Segment- Specialty Benefits- Fees and other revenues' is projected to be $9.13 million, indicating an +8.7% change [6]. - 'Revenue- Benefits and Protection Segment- Specialty Benefits- Premiums and other considerations' is expected to reach $834.00 million, reflecting a +3.6% change [7]. Additional Segment Insights - The total revenue for 'Benefits and Protection Segment- Specialty Benefits' is estimated at $894.05 million, suggesting a +4.2% change year-over-year [8]. - 'Revenue- Benefits and Protection Segment- Life Insurance- Fees and other revenues' is projected at $96.98 million, indicating a -9.1% change [8]. - 'Revenue- Benefits and Protection Segment- Life Insurance- Total' is expected to be $301.70 million, reflecting an -8.3% change from the prior year [10]. Stock Performance - Principal Financial shares have increased by +2.9% over the past month, compared to a +5.9% increase in the Zacks S&P 500 composite [10].

Core Viewpoint - Woodward (WWD) is expected to report quarterly earnings of $1.62 per share, a slight decline of 0.6% year-over-year, while revenues are projected to increase by 4.7% to $887.75 million [1]. Earnings Projections - Analysts have revised the consensus EPS estimate upward by 2% over the past 30 days, indicating a collective reassessment of initial projections [2]. - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - The 'Segment external net sales- Industrial' is estimated at $299.84 million, reflecting a year-over-year decline of 9.2% [5]. - The 'Segment external net sales- Aerospace' is projected to be $589.56 million, indicating a year-over-year increase of 13.9% [5]. Segment Sales Projections - 'Aerospace segment net sales- Defense aftermarket' is expected to reach $65.62 million, showing no change from the prior year [6]. - 'Aerospace segment net sales- Commercial aftermarket' is projected at $192.43 million, reflecting a year-over-year increase of 16.1% [6]. - 'Aerospace segment net sales- Commercial OEM' is estimated at $198.05 million, indicating a 4.4% increase year-over-year [7]. - 'Aerospace segment net sales- Defense OEM' is expected to reach $135.84 million, reflecting a significant year-over-year increase of 40.7% [7]. Earnings by Segment - The estimated 'Segment earnings- Aerospace' is projected at $124.22 million, compared to $101.84 million in the same quarter last year [8]. - The average prediction for 'Segment earnings (loss)- Industrial' is $39.53 million, down from $59.72 million year-over-year [8]. Stock Performance - Over the past month, Woodward shares have returned +3.6%, compared to a +5.9% change in the Zacks S&P 500 composite [8]. - Woodward holds a Zacks Rank 2 (Buy), suggesting it is likely to outperform the overall market in the upcoming period [8].

Core Viewpoint - Lear (LEA) is expected to report quarterly earnings of $3.23 per share, reflecting a decline of 10.3% year-over-year, with revenues forecasted at $5.89 billion, a decrease of 2% compared to the previous year [1] Earnings Projections - Changes in earnings projections are crucial for predicting investor reactions to the stock, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [2] Analysts' Consensus on Key Metrics - Analysts forecast 'Net Sales- E-Systems' to be $1.52 billion, indicating a year-over-year decline of 2.9% [4] - 'Net Sales- Seating' is projected to reach $4.37 billion, reflecting a decrease of 1.7% from the same quarter last year [4] - 'Geographic Net Sales- South America' is expected to be $235.04 million, showing an increase of 9.9% year-over-year [4] - 'Geographic Net Sales- North America' is estimated at $2.44 billion, indicating a decline of 4.6% [5] - 'Geographic Net Sales- Europe and Africa' is projected to be $2.13 billion, reflecting a decrease of 1.8% [5] - 'Geographic Net Sales- Asia' is expected to reach $1.13 billion, indicating an increase of 5.4% from the prior year [5] Adjusted Segment Earnings - 'Adjusted Segment Earnings- E-Systems' is estimated at $66.73 million, down from $82.20 million in the same quarter last year [6] - 'Adjusted Segment Earnings- Seating' is projected to be $276.06 million, compared to $302.10 million in the previous year [6] Stock Performance - Shares of Lear have increased by 14.4% over the past month, outperforming the Zacks S&P 500 composite, which rose by 5.9% [6]

It is projected by analysts that the 'Total non-performing assets' will reach $46.46 million. Compared to the current estimate, the company reported $18.01 million in the same quarter of the previous year. Wall Street analysts forecast that Glacier Bancorp (GBCI) will report quarterly earnings of $0.47 per share in its upcoming release, pointing to a year-over-year increase of 20.5%. It is anticipated that revenues will amount to $243.5 million, exhibiting an increase of 22.6% compared to the year-ago quart ...